Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Gertjan J L Kaspers"'
Autor:
Romy E. Van Weelderen, Kim Klein, Bianca F. Goemans, Wim J. E. Tissing, Tom F. W. Wolfs, Gertjan J. L. Kaspers
Publikováno v:
Cancers; Volume 14; Issue 13; Pages: 3172
Cancers, 14(13):3172. Multidisciplinary Digital Publishing Institute (MDPI)
Cancers, 14(13):3172. MDPI AG
van Weelderen, R E, Klein, K, Goemans, B F, Tissing, W J E, Wolfs, T F W & Kaspers, G J L 2022, ' Effect of Antibacterial Prophylaxis on Febrile Neutropenic Episodes and Bacterial Bloodstream Infections in Dutch Pediatric Patients with Acute Myeloid Leukemia : A Two-Center Retrospective Study ', Cancers, vol. 14, no. 13, 3172 . https://doi.org/10.3390/cancers14133172
Cancers, 14(13):3172. Multidisciplinary Digital Publishing Institute (MDPI)
Cancers, 14(13):3172. MDPI AG
van Weelderen, R E, Klein, K, Goemans, B F, Tissing, W J E, Wolfs, T F W & Kaspers, G J L 2022, ' Effect of Antibacterial Prophylaxis on Febrile Neutropenic Episodes and Bacterial Bloodstream Infections in Dutch Pediatric Patients with Acute Myeloid Leukemia : A Two-Center Retrospective Study ', Cancers, vol. 14, no. 13, 3172 . https://doi.org/10.3390/cancers14133172
Simple Summary The intensive chemotherapy that children with acute myeloid leukemia (AML) receive puts them at high risk of infections. Bloodstream infections (BSI) caused by bacteria are common and known for their associated complications but may be
Autor:
Romy E. vanWeelderen, Noa E. Wijnen, Festus Njuguna, Kim Klein, Terry A. Vik, Gilbert Olbara, Gertjan J. L. Kaspers
Publikováno v:
Cancer Reports, Vol 6, Iss 8, Pp n/a-n/a (2023)
Abstract Purpose The Pediatric Oncology in Developing Countries (PODC) committee of the International Society of Pediatric Oncology (SIOP) published a pediatric acute myeloid leukemia (AML)‐specific adapted treatment guideline for low‐ and middle
Externí odkaz:
https://doaj.org/article/0e781670d4804313958399266d416fe9
Autor:
Romy E. vanWeelderen, Festus Njuguna, Kim Klein, Saskia Mostert, Sandra Langat, Terry A. Vik, Gilbert Olbara, Martha Kipng'etich, Gertjan J. L. Kaspers
Publikováno v:
Cancer Reports, Vol 5, Iss 10, Pp n/a-n/a (2022)
Abstract Background Pediatric acute myeloid leukemia (AML) is a challenging disease to treat in low‐ and middle‐income countries (LMICs). Literature suggests that survival in LMICs is poorer compared with survival in high‐income countries (HICs
Externí odkaz:
https://doaj.org/article/4644c2e45df34afd9d978f50cf8d59b8